Ali Fuat Gürbüz (Ali Fuat Gurbuz)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Peritoneal Dialysis

Coronavirus Disease

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

Hormone molecular biology and clinical investigation

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

This page only lists publications with an associated author ORCID identifier.

Publications

Ali Fuat Gürbüz, Melek Karakurt Eryılmaz, Oğuzhan Yıldız, Fahriye Kılınç, Murat Araz, Mehmet Artaç
Rare case of myelodysplastic syndrome with excess blasts 2 developing after adjuvant chemoradiotherapy for triple-negative breast cancer in a patient with Bloom syndrome. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2024)
Ali Fuat Gürbüz, Melek Karakurt Eryilmaz, Oğuzhan Yıldız, Bahattin Engin Kaya, Murat Araz, Mustafa Yıldırım
Lorlatinib experience in a patient with ALK + non-small cell lung cancer on hemodialysis: A case report. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2024)
Kamile Yucel, Ali Fuat Gürbüz
Hypoxia-inducible factor-1α and ischemia-modified albumin levels in intensive care COVID-19 Patients. Hormone molecular biology and clinical investigation (2022)